Mineralys Therapeutics, Inc. earnings per share and revenue

MLYS earnings per share for the last quarter are -1.13 USD whereas the estimation was -0.86 USD which accounts for -30.89% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -1.04 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of MLYS earnings per share and revenue dynamics.